Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||
| Net Income | -647 | -1,580 |
| Other Working Capital | 79 | 80 |
| Other Operating Activity | 0 | 600 |
| Operating Cash Flow | $-568 | $-900 |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $N/A | $0 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 1,850 | N/A |
| Other Financing Activity | 0 | 900 |
| Financing Cash Flow | $1,850 | $900 |
| Beginning Cash Position | 200 | 200 |
| End Cash Position | 1,482 | 200 |
| Net Cash Flow | $1,282 | $-9 |
| Free Cash Flow | ||
| Operating Cash Flow | -568 | -900 |
| Free Cash Flow | -568 | -900 |